Substance Use Disorders Among Inpatients with Bipolar Disorder and Major Depressive Disorder in a General Hospital

1998 ◽  
Vol 20 (2) ◽  
pp. 98-101 ◽  
Author(s):  
C Lin
2012 ◽  
Vol 73 (06) ◽  
pp. 865-873 ◽  
Author(s):  
Carlos Blanco ◽  
Analucía A. Alegría ◽  
Shang-Min Liu ◽  
Roberto Secades-Villa ◽  
Luisa Sugaya ◽  
...  

2019 ◽  
pp. 3-32
Author(s):  
William W. Eaton ◽  
O. Joseph Bienvenu ◽  
Gerald Nestadt ◽  
Heather E. Volk ◽  
James C. Anthony

This chapter describes seventeen important mental disorders and reviews studies of the prevalence of the disorders from around the world, presenting median and interquartile ranges for more than four hundred research studies. The range of prevalences is below 0.5% for eating disorders and schizophrenia, and above 5% for attention deficit hyperactivity disorder, major depressive disorder, phobias, personality disorders, and dementia. The chapter discusses methods for judging the disability adjusted life years (DALYs) for the disorders and compares estimates to other diseases considered in the Global Burden of Disease study. Mental and substance use disorders account for more than 160 million of the total DALYs in the world, or about 7% of the total. Major depressive disorder is the leading causes of DALYs among the mental and substance use disorders.


2002 ◽  
Vol 59 (11) ◽  
pp. 1039 ◽  
Author(s):  
David W. Brook ◽  
Judith S. Brook ◽  
Chenshu Zhang ◽  
Patricia Cohen ◽  
Martin Whiteman

Author(s):  
J. Corey Williams ◽  
Gustavo A. Angarita Africano

This chapter provides a summary of a landmark study on the treatment of major depressive disorder and co-morbid substance use disorders. Are antidepressants efficacious in treatment of combined depression and substance use disorders? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The main study findings suggest that Major Depressive Disorder can be effectively treated with antidepressant medications in patients with co-morbid substance use disorders. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.


Sign in / Sign up

Export Citation Format

Share Document